Standard
Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia : A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma. / Andersen, Michael Asger; Valentin, Rebecca; Sjö, Lene Dissing; Borgwardt, Line; Schmiegelow, Kjeld; Andersen, Mette Klarskov; Marvig, Rasmus L.; Yde, Christina Westmose; Niemann, Carsten Utoft.
In:
Acta Oncologica, Vol. 59, No. 12, 2020, p. 1547-1551.
Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
Andersen, MA, Valentin, R
, Sjö, LD, Borgwardt, L
, Schmiegelow, K, Andersen, MK, Marvig, RL, Yde, CW
& Niemann, CU 2020, '
Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia: A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma',
Acta Oncologica, vol. 59, no. 12, pp. 1547-1551.
https://doi.org/10.1080/0284186X.2020.1821913APA
Andersen, M. A., Valentin, R.
, Sjö, L. D., Borgwardt, L.
, Schmiegelow, K., Andersen, M. K., Marvig, R. L., Yde, C. W.
, & Niemann, C. U. (2020).
Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia: A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma.
Acta Oncologica,
59(12), 1547-1551.
https://doi.org/10.1080/0284186X.2020.1821913Vancouver
Andersen MA, Valentin R
, Sjö LD, Borgwardt L
, Schmiegelow K, Andersen MK et al.
Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia: A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma.
Acta Oncologica. 2020;59(12):1547-1551.
https://doi.org/10.1080/0284186X.2020.1821913Author
Andersen, Michael Asger ; Valentin, Rebecca ; Sjö, Lene Dissing ; Borgwardt, Line ; Schmiegelow, Kjeld ; Andersen, Mette Klarskov ; Marvig, Rasmus L. ; Yde, Christina Westmose ; Niemann, Carsten Utoft. / Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia : A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma. In: Acta Oncologica. 2020 ; Vol. 59, No. 12. pp. 1547-1551.
Bibtex
@article{497cc3caea5c4ea0922e64dff9543671,
title = "Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia: A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma",
author = "Andersen, {Michael Asger} and Rebecca Valentin and Sj{\"o}, {Lene Dissing} and Line Borgwardt and Kjeld Schmiegelow and Andersen, {Mette Klarskov} and Marvig, {Rasmus L.} and Yde, {Christina Westmose} and Niemann, {Carsten Utoft}",
year = "2020",
doi = "10.1080/0284186X.2020.1821913",
language = "English",
volume = "59",
pages = "1547--1551",
journal = "Acta Oncologica",
issn = "1100-1704",
publisher = "Taylor & Francis",
number = "12",
}
RIS
TY - JOUR
T1 - Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia
T2 - A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma
AU - Andersen, Michael Asger
AU - Valentin, Rebecca
AU - Sjö, Lene Dissing
AU - Borgwardt, Line
AU - Schmiegelow, Kjeld
AU - Andersen, Mette Klarskov
AU - Marvig, Rasmus L.
AU - Yde, Christina Westmose
AU - Niemann, Carsten Utoft
PY - 2020
Y1 - 2020
U2 - 10.1080/0284186X.2020.1821913
DO - 10.1080/0284186X.2020.1821913
M3 - Comment/debate
C2 - 32970500
VL - 59
SP - 1547
EP - 1551
JO - Acta Oncologica
JF - Acta Oncologica
SN - 1100-1704
IS - 12
ER -
